REFRACTORY ACUTE LEUKEMIA
Clinical trials for REFRACTORY ACUTE LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail tested for leukemia that Won't quit
Disease control OngoingThis study is testing whether a combination of three drugs—chidamide, azacitidine, and the HAG regimen—can help control acute myeloid leukemia (AML) in adults when the cancer has come back or hasn't responded to previous treatments. The main goal is to see how well this combinati…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Targeted drug trial offers hope for kids with rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing a targeted drug called larotrectinib in children and young adults (up to age 30) with specific types of cancer. The cancers must have a rare genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control leukemia before other…
Matched conditions: REFRACTORY ACUTE LEUKEMIA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC